Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for hyperphosphatasia-intellectual disability syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hyperphosphatasia-intellectual disability syndrome.
210 publications have been identified in PubMed for hyperphosphatasia-intellectual disability syndrome. Research spans Review / Meta-Analysis (33%), Epidemiology / Natural History (30%), and Case Report / Case Series (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 68 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:06 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
62 |
30% |
Patient case studies | 40 | 19% |
Laboratory research | 22 | 11% |
Clinical study results | 7 | 3% |
Testing and diagnosis research | 5 | 2% |
Other research | 2 | 1% |
Feng Z (2026). [PMID: 41795174](https://pubmed.ncbi.nlm.nih.gov/41795174/). *Am J Med Genet A*. [Diagnostic / Biomarker]
Nezamdoust B (2026). [PMID: 41223774](https://pubmed.ncbi.nlm.nih.gov/41223774/). *Soc Sci Med*. [Epidemiology / Natural History]
VanSickle EA (2026). [PMID: 41410504](https://pubmed.ncbi.nlm.nih.gov/41410504/). *Am J Med Genet A*. [Review / Meta-Analysis]
Whitby-Tillott H (2026). [PMID: 41603202](https://pubmed.ncbi.nlm.nih.gov/41603202/). *J Appl Res Intellect Disabil*. [Case Report / Case Series]
Xu X (2026). [PMID: 42138082](https://pubmed.ncbi.nlm.nih.gov/42138082/). *J Clin Invest*. [Basic Science / Preclinical]
Mesina RS Jr (2026). [PMID: 40974761](https://pubmed.ncbi.nlm.nih.gov/40974761/). *Intensive Crit Care Nurs*. [Epidemiology / Natural History]
Beşen Ş (2026). [PMID: 41622609](https://pubmed.ncbi.nlm.nih.gov/41622609/). *Annals of Indian Academy of Neurology*. [Case Report / Case Series]
Sarimski K (2026). [PMID: 41979662](https://pubmed.ncbi.nlm.nih.gov/41979662/). *Nervenarzt*. [Review / Meta-Analysis]
Ghawi OE (2026). [PMID: 42153462](https://pubmed.ncbi.nlm.nih.gov/42153462/). *J Child Neurol*. [Review / Meta-Analysis]
Vijayaraghavan N (2026). [PMID: 41207727](https://pubmed.ncbi.nlm.nih.gov/41207727/). *Phys Med Rehabil Clin N Am*. [Review / Meta-Analysis]